Ainos (OTCMKTS:AIMD) Stock Price Down 1.9% – Should You Sell?

Ainos, Inc. (OTCMKTS:AIMD) fell 1.9% on Friday . The company traded as low as $0.50 and last traded at $0.51. 38,478 shares were traded during trading, a decline of 93% from the average session volume of 553,912 shares. The stock had previously closed at $0.52.

Ainos Price Performance

The company has a quick ratio of 1.45, a current ratio of 1.92 and a debt-to-equity ratio of 0.08. The firm has a market cap of $7.87 million, a P/E ratio of -0.59 and a beta of 1.51. The business’s 50 day moving average is $0.60 and its two-hundred day moving average is $0.53.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.